← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Cyanvac, Llc
Athens, GA
$758,874
Total funding
3
Grants
Funding over time
peak $407K · FY2022–24$500K$375K$250K$125K$0
'22
'23
'24
Funding mix
By agency
NIH$758,874 · 3
By mechanism
R43$399,999 · 2
R21$358,875 · 1
Investigators at Cyanvac, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Developing a PIV5-based human metapneumovirus (HMPV) vaccine$249,999
R43 · FY2023 · AI
A parainfluenza virus 5 (PIV5)-based bivalent vaccine for respiratory syncytial virus (RSV) and human metapneumovirus (HMPV)$201,900
R21 · FY2024 · AI
A parainfluenza virus 5 (PIV5)-based bivalent vaccine for respiratory syncytial virus (RSV) and human metapneumovirus (HMPV)$156,975
R21 · FY2023 · AI
Developing a liquid formulation for CVXGA1 COVID-19 intranasal vaccine$150,000
R43 · FY2022 · AI